↓ Skip to main content

Cochrane Database of Systematic Reviews

Medical anti-shock trousers (pneumatic anti-shock garments) for circulatory support in patients with trauma

Overview of attention for article published in Cochrane database of systematic reviews, October 1999
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (89th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (58th percentile)

Mentioned by

news
1 news outlet
twitter
5 tweeters
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
59 Dimensions

Readers on

mendeley
77 Mendeley
Title
Medical anti-shock trousers (pneumatic anti-shock garments) for circulatory support in patients with trauma
Published in
Cochrane database of systematic reviews, October 1999
DOI 10.1002/14651858.cd001856
Pubmed ID
Authors

Ian Roberts, Karen Blackhall, Karen Joanna Dickinson

Abstract

Medical antishock trousers (MAST) have been used to increase venous return to the heart until definitive care could be given. This, combined with compression of blood vessels, is believed to cause the movement of blood from the lower body to the brain, heart and lungs. However, the equipment is expensive, and may have adverse effects. To quantify the effect on mortality and morbidity of the use of medical anti-shock trousers (MAST)/ pneumatic anti-shock garments (PASG) in patients following trauma. Trials were identified by searches of the Cochrane Injuries Group Trials Register, the Cochrane Controlled Trials Register, MEDLINE, EMBASE, BIDS ISI Service and Science Citation Index. References in relevant papers identified were followed up. A citation analysis of references to randomised controlled trials was conducted using the Science Citation Index. Authors of identified trials were contacted and asked about any other trials that may have been conducted, whether published or unpublished. Randomised and quasi-randomised trials of MAST/PASG in patients following trauma (excluding fractures of the extremities in which MAST/PASG may be used as a splint). Data were extracted independently by two reviewers. Data were collected on mortality, duration of hospitalisation and ICU stay, and quality of allocation concealment. Two trials were identified that met the inclusion criteria. These trials included 1202 randomised patients in total; however, data for only 1075 of these were available. The relative risk of death with MAST was 1.13 (95% CI 0.97 to 1.32). Duration of hospitalisation and of intensive care unit stay was longer in the MAST treated group. The weighted mean difference in the length of intensive care unit stay was 1.7 days (95% CI 0.33 to 2.98). There is no evidence to suggest that MAST/PASG application reduces mortality, length of hospitalisation or length of ICU stay in trauma patients and it is possible that it may increase these. These data do not support the continued use of MAST/PASG in the situation described. However, it should be recognised that, due to the poor quality of the trials, conclusions should be drawn with caution.

Twitter Demographics

The data shown below were collected from the profiles of 5 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 77 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 1%
Kazakhstan 1 1%
Unknown 75 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 11 14%
Student > Bachelor 11 14%
Student > Master 10 13%
Student > Ph. D. Student 8 10%
Professor 5 6%
Other 13 17%
Unknown 19 25%
Readers by discipline Count As %
Medicine and Dentistry 30 39%
Engineering 5 6%
Nursing and Health Professions 4 5%
Unspecified 2 3%
Agricultural and Biological Sciences 2 3%
Other 9 12%
Unknown 25 32%

Attention Score in Context

This research output has an Altmetric Attention Score of 16. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 September 2022.
All research outputs
#1,891,925
of 22,078,848 outputs
Outputs from Cochrane database of systematic reviews
#4,233
of 12,178 outputs
Outputs of similar age
#25,969
of 251,536 outputs
Outputs of similar age from Cochrane database of systematic reviews
#105
of 248 outputs
Altmetric has tracked 22,078,848 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,178 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 29.9. This one has gotten more attention than average, scoring higher than 65% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 251,536 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 248 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 58% of its contemporaries.